Deadline: 28-Apr-2026
Defeat Duchenne Canada is inviting applications for its Research Grant to support innovative research on Duchenne muscular dystrophy (DMD) aimed at improving health outcomes and quality of life for people living with the condition. The grant supports discovery, translational, supportive, and clinical research, and is open to Canadian and international researchers with eligible institutional affiliations.
What is the Defeat Duchenne Canada Research Grant?
The Defeat Duchenne Canada Research Grant is a funding opportunity for researchers working on Duchenne muscular dystrophy (DMD).
The programme supports high-impact, patient-focused research that can improve:
The grant prioritizes projects with strong potential for practical, timely, and cost-effective translation into clinical practice.
Research Focus Areas
The grant supports multiple types of Duchenne muscular dystrophy research.
Eligible Research Areas
- Discovery research
- Translational research
- Supportive research
- Clinical research
Priority Themes
Projects should ideally demonstrate:
- Innovation
- Patient-centered design
- Potential to improve clinical care
- Potential to enhance quality of life
- Potential to reduce the burden of illness for:
- Patients
- Families
- Caregivers
Why This Grant Matters
Duchenne muscular dystrophy is a serious genetic neuromuscular disorder that requires ongoing advances in treatment, care, and support.
This grant is important because it encourages research that is not only scientifically strong, but also:
- Relevant to real patient needs
- Clinically meaningful
- Practical for implementation
- Focused on faster translation into healthcare settings
Defeat Duchenne Canada also emphasizes collaboration between academics and clinicians, which increases the likelihood of real-world impact.
Who is Eligible?
Principal Investigator (PI) Eligibility
To apply as a Principal Investigator, the applicant must:
- Hold an advanced degree, such as:
- MD
- PhD
- Or equivalent qualification
- Be affiliated with an eligible institution
Eligible Institutions
Applicants must be affiliated with institutions such as:
- Universities
- Hospitals
- Research institutes
- Other relevant organizations
Geographic Eligibility
- Canadian applicants are eligible
- International applicants are also eligible
Important Legal Condition
International and Canadian applicants must ensure that their institution can comply with the legal requirements under the laws of Ontario, Canada.
Who Cannot Apply as Principal Investigator?
The following individuals cannot apply as PI:
- Graduate students
- Postdoctoral researchers
- Other trainees
However, they may still participate as:
- Co-applicants
- Co-investigators
- Research team members
Application Limits
Submission Rule
- Each applicant may submit only one application as Principal Investigator
Co-Investigator Flexibility
- Co-investigators may participate in multiple applications
This means a researcher can only lead one proposal, but can still collaborate on others.
What Makes a Strong Proposal?
A strong application should clearly show:
- A well-defined Duchenne muscular dystrophy research question
- Strong innovation
- Clear patient benefit
- Relevance to clinical care or quality of life
- Feasibility and scientific strength
- Potential for timely translation into practice
- Good value and cost-effective impact
- Strong collaboration between researchers and clinicians
How to Apply
Step-by-Step Application Tips
- Confirm PI eligibility
Make sure you hold an eligible advanced degree and institutional affiliation. - Check institutional compliance
Ensure your institution can meet the legal requirements under Ontario, Canada. - Choose one strong project
Since only one PI submission is allowed, select your most competitive proposal. - Align with priority areas
Frame your project under:- Discovery
- Translational
- Supportive
- Clinical research
- Emphasize patient impact
Clearly explain how the project may improve:- Care
- Outcomes
- Daily living
- Caregiver burden
- Show translation potential
Highlight why the findings could be applied in practice in a timely and cost-effective way. - Build a strong team
Include clinicians, researchers, and trainees where relevant.
Common Mistakes to Avoid
Avoid these common errors:
- Submitting a project with weak relevance to Duchenne muscular dystrophy
- Focusing only on basic science without explaining clinical relevance
- Failing to show patient-centered impact
- Ignoring the importance of translation into practice
- Having a trainee listed as Principal Investigator
- Submitting more than one PI-led application
- Not addressing institutional eligibility or legal compliance
FAQ
1. What is the Defeat Duchenne Canada Research Grant?
It is a research funding opportunity that supports innovative Duchenne muscular dystrophy research aimed at improving health, care, and quality of life for people living with DMD.
2. What research areas are supported?
The grant supports:
- Discovery research
- Translational research
- Supportive research
- Clinical research
3. Who can apply as Principal Investigator?
The PI must:
- Hold an advanced degree such as MD, PhD, or equivalent
- Be affiliated with an eligible institution such as a university, hospital, or research institute
4. Are international applicants eligible?
Yes. Both Canadian and international applicants are eligible, provided their institutions can comply with Ontario, Canada legal requirements.
5. Can graduate students or postdocs apply as PI?
No. Trainees, including graduate students and postdoctoral researchers, cannot apply as Principal Investigator.
6. Can trainees still be part of the project?
Yes. Trainees may be included as:
- Co-applicants
- Co-investigators
- Research team members
7. How many applications can one PI submit?
An applicant may submit only one application as Principal Investigator, but may join multiple proposals as a co-investigator.
Conclusion
The Defeat Duchenne Canada Research Grant is a valuable opportunity for researchers developing innovative, patient-centered solutions for Duchenne muscular dystrophy.
For more information, visit Defeat Duchenne Canada.